Fresenius Kabi Recalls Morphine Syringes Due to Labeling Error
Fresenius Kabi is recalling 625,500 Morphine Sulfate syringes because some were mislabeled and contained Dilaudid instead.
What this means for you
Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The agency classification is FDA Class I, which indicates a reasonable probability that use of the product will cause serious adverse health consequences or death.
Plain-English summary
Fresenius Kabi USA, LLC is recalling 625,500 units of Morphine Sulfate Injection, USP, 2 mg/mL, 1 mL single-dose Simplist prefilled syringes. The recall is due to a labeling error where MicroVault units were labeled as Morphine 2 mg/1 mL but actually contained a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.
The affected product is identified by Lot # 6402820 with an expiration date of 12/2028. The product was distributed nationwide within the USA. The NDC numbers for the unit of use and unit of sale are 76045-004-01 and 76045-004-11, respectively.
Healthcare providers and consumers should check their inventory for this specific lot number and stop using the product if it matches the description. They should contact Fresenius Kabi USA, LLC for further instructions on how to return or dispose of the affected syringes.
The recalled product
- Product
- MORPHINE SULFATE (MORPHINE SULFATE)
- Brand
- MORPHINE SULFATE
- Manufacturer
- Fresenius Kabi USA, LLC
- Category
- Drug — Prescription Injection
- Hazard
- Affected units
- 625,500
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 6402820
- Exp. Date 12/2028
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · MORPHINE SULFATE
- ModerateMorphine sulfate oral solution recalled over a carton size mismatch
FDA (Drugs) · 2025-12-17
- HighMorphine Sulfate Tablets Recalled Over Failed Dissolution Specifications
FDA (Drugs) · 2025-03-12
- SevereMorphine Sulfate Injection Recalled Due to Defective Vials
FDA (Drugs) · 2021-10-06
- ModerateLupin Recalls Morphine Sulfate Tablets for Impurity Specification Failures
FDA (Drugs) · 2019-05-01
- ModerateLupin Recalls Morphine Sulfate Extended-Release Tablets Due to Impurity Failures
FDA (Drugs) · 2019-05-01
Same manufacturer · Fresenius Kabi USA, LLC
See all →- SevereFresenius Kabi Recalls Tyenne Injection Due to Glass Particles
FDA (Drugs) · 2026-09-02
- HighXylocaine Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- ModerateFDA Recalls Xylocaine Injections Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- ModerateGlycopyrrolate Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- HighLidocaine Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02